vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Civeo Corp (CVEO). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $161.6M, roughly 1.5× Civeo Corp). Civeo Corp runs the higher net margin — -4.0% vs -35.0%, a 31.0% gap on every dollar of revenue. On growth, Civeo Corp posted the faster year-over-year revenue change (7.1% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $14.5M). Over the past eight quarters, Civeo Corp's revenue compounded faster (-1.4% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.
CCRN vs CVEO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $161.6M |
| Net Profit | $-82.9M | $-6.5M |
| Gross Margin | — | 22.7% |
| Operating Margin | -30.2% | -0.1% |
| Net Margin | -35.0% | -4.0% |
| Revenue YoY | -23.6% | 7.1% |
| Net Profit YoY | -2109.7% | 58.1% |
| EPS (diluted) | $-2.56 | $-0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $161.6M | ||
| Q3 25 | $250.1M | $170.5M | ||
| Q2 25 | $274.1M | $162.7M | ||
| Q1 25 | $293.4M | $144.0M | ||
| Q4 24 | $309.9M | $151.0M | ||
| Q3 24 | $315.1M | $176.3M | ||
| Q2 24 | $339.8M | $188.7M | ||
| Q1 24 | $379.2M | $166.1M |
| Q4 25 | $-82.9M | $-6.5M | ||
| Q3 25 | $-4.8M | $-455.0K | ||
| Q2 25 | $-6.7M | $-3.3M | ||
| Q1 25 | $-490.0K | $-9.8M | ||
| Q4 24 | $-3.8M | $-15.4M | ||
| Q3 24 | $2.6M | $-5.1M | ||
| Q2 24 | $-16.1M | $8.2M | ||
| Q1 24 | $2.7M | $-5.1M |
| Q4 25 | — | 22.7% | ||
| Q3 25 | 20.4% | 25.7% | ||
| Q2 25 | 20.4% | 25.3% | ||
| Q1 25 | 20.0% | 20.4% | ||
| Q4 24 | — | 18.6% | ||
| Q3 24 | 20.4% | 21.4% | ||
| Q2 24 | 20.8% | 25.4% | ||
| Q1 24 | 20.4% | 21.5% |
| Q4 25 | -30.2% | -0.1% | ||
| Q3 25 | -2.4% | 4.1% | ||
| Q2 25 | -2.1% | 1.7% | ||
| Q1 25 | -0.3% | -3.8% | ||
| Q4 24 | -1.1% | -6.7% | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | -5.7% | 6.9% | ||
| Q1 24 | 0.8% | -1.1% |
| Q4 25 | -35.0% | -4.0% | ||
| Q3 25 | -1.9% | -0.3% | ||
| Q2 25 | -2.4% | -2.0% | ||
| Q1 25 | -0.2% | -6.8% | ||
| Q4 24 | -1.2% | -10.2% | ||
| Q3 24 | 0.8% | -2.9% | ||
| Q2 24 | -4.7% | 4.4% | ||
| Q1 24 | 0.7% | -3.1% |
| Q4 25 | $-2.56 | $-0.58 | ||
| Q3 25 | $-0.15 | $-0.04 | ||
| Q2 25 | $-0.20 | $-0.25 | ||
| Q1 25 | $-0.02 | $-0.72 | ||
| Q4 24 | $-0.13 | $-1.04 | ||
| Q3 24 | $0.08 | $-0.36 | ||
| Q2 24 | $-0.47 | $0.56 | ||
| Q1 24 | $0.08 | $-0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $14.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $174.4M |
| Total Assets | $449.0M | $477.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $14.4M | ||
| Q3 25 | $99.1M | $12.0M | ||
| Q2 25 | $81.2M | $14.6M | ||
| Q1 25 | $80.7M | $28.4M | ||
| Q4 24 | $81.6M | $5.2M | ||
| Q3 24 | $64.0M | $17.9M | ||
| Q2 24 | $69.6M | $7.4M | ||
| Q1 24 | $5.2M | $16.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $43.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $322.8M | $174.4M | ||
| Q3 25 | $408.1M | $182.5M | ||
| Q2 25 | $412.2M | $209.4M | ||
| Q1 25 | $418.2M | $220.7M | ||
| Q4 24 | $419.0M | $236.4M | ||
| Q3 24 | $424.7M | $282.2M | ||
| Q2 24 | $433.3M | $297.4M | ||
| Q1 24 | $462.4M | $297.4M |
| Q4 25 | $449.0M | $477.4M | ||
| Q3 25 | $538.2M | $491.1M | ||
| Q2 25 | $553.8M | $508.8M | ||
| Q1 25 | $576.2M | $423.8M | ||
| Q4 24 | $589.3M | $405.1M | ||
| Q3 24 | $597.4M | $477.6M | ||
| Q2 24 | $602.9M | $483.2M | ||
| Q1 24 | $648.4M | $513.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $19.3M |
| Free Cash FlowOCF − Capex | $16.1M | $14.5M |
| FCF MarginFCF / Revenue | 6.8% | 8.9% |
| Capex IntensityCapex / Revenue | 0.9% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $19.3M | ||
| Q3 25 | $20.1M | $13.8M | ||
| Q2 25 | $4.2M | $-2.3M | ||
| Q1 25 | $5.7M | $-8.4M | ||
| Q4 24 | $24.2M | $9.5M | ||
| Q3 24 | $7.5M | $35.7M | ||
| Q2 24 | $82.4M | $32.4M | ||
| Q1 24 | $6.0M | $6.0M |
| Q4 25 | $16.1M | $14.5M | ||
| Q3 25 | $17.9M | $8.2M | ||
| Q2 25 | $2.3M | $-6.8M | ||
| Q1 25 | $3.8M | $-13.7M | ||
| Q4 24 | $21.7M | $1.8M | ||
| Q3 24 | $6.3M | $28.2M | ||
| Q2 24 | $79.6M | $27.0M | ||
| Q1 24 | $3.8M | $372.0K |
| Q4 25 | 6.8% | 8.9% | ||
| Q3 25 | 7.2% | 4.8% | ||
| Q2 25 | 0.8% | -4.2% | ||
| Q1 25 | 1.3% | -9.5% | ||
| Q4 24 | 7.0% | 1.2% | ||
| Q3 24 | 2.0% | 16.0% | ||
| Q2 24 | 23.4% | 14.3% | ||
| Q1 24 | 1.0% | 0.2% |
| Q4 25 | 0.9% | 3.0% | ||
| Q3 25 | 0.9% | 3.3% | ||
| Q2 25 | 0.7% | 2.8% | ||
| Q1 25 | 0.6% | 3.7% | ||
| Q4 24 | 0.8% | 5.1% | ||
| Q3 24 | 0.4% | 4.2% | ||
| Q2 24 | 0.8% | 2.8% | ||
| Q1 24 | 0.6% | 3.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | 3.93× | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
CVEO
Segment breakdown not available.
